In neuroblastoma, MYCN amplification occurs in approximately 25% of neuroblastoma cases; MYCN oncogene activation through amplification is an important hallmark of advanced tumor stage and poor prognosis [22]. This evidence concerns the gene MYCN and neoplasm.